Jiang D, Reches A, Fahn S
Neurology. 1983 Jun;33(6):793-6. doi: 10.1212/wnl.33.6.793.
We measured the kinetic constants for the unidirectional influx of L-DOPA into red blood cells of patients with Parkinson's disease (seven patients), Huntington's disease (seven patients), and other extrapyramidal diseases (11 patients), and in five controls. Influx consisted of two components with low affinity and high exchange capacity. In individual subjects, the L-DOPA concentration giving half-maximal influx (Km) varied between 0.04 and 2.19 mM, and the maximum velocity (Vmax) of the saturable transport component was between 20 and 578 mumol/l cell water/h, which is compatible with the neutral amino acids of low affinity for the transport system. The range of Kd (the first-order rate constant for the unsaturable component) was between 0.11 and 0.36 hour-1. There was no gross deficit of the L-DOPA uptake process in patients with Parkinson's disease, Huntington's disease, dystonia, or other extrapyramidal diseases.
我们测定了帕金森病患者(7例)、亨廷顿病患者(7例)和其他锥体外系疾病患者(11例)以及5名对照者红细胞中L-多巴单向流入的动力学常数。流入由两个具有低亲和力和高交换能力的成分组成。在个体受试者中,产生半数最大流入量的L-多巴浓度(Km)在0.04至2.19 mM之间变化,可饱和转运成分的最大速度(Vmax)在20至578 μmol/升细胞水/小时之间,这与对转运系统低亲和力的中性氨基酸相符。Kd(不饱和成分的一级速率常数)范围在0.11至0.36小时-1之间。帕金森病、亨廷顿病、肌张力障碍或其他锥体外系疾病患者的L-多巴摄取过程没有明显缺陷。